Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalMarket CapitalizationReturn on AssetsReturn on Capital EmployedReturn on Equity

Artiva Biotherapeutics (ARTV) Gross Margin: 2023-2024

Historic Gross Margin for Artiva Biotherapeutics (ARTV) over the last 1 years, with Mar 2024 value amounting to 100.00%.

  • Artiva Biotherapeutics' Gross Margin was N/A to 100.00% in Q1 2024 from the same period last year, while for Mar 2024 it was 100.00%, marking a year-over-year change of. This contributed to the annual value of 100.00% for FY2024, which is negligibly% changed negligibly from last year.
  • As of Q1 2024, Artiva Biotherapeutics' Gross Margin stood at 100.00%, which was down 0.00% from 100.00% recorded in Q4 2023.
  • Artiva Biotherapeutics' 5-year Gross Margin high stood at 100.00% for Q2 2023, and its period low was 100.00% during Q2 2023.
  • Its 2-year average for Gross Margin is 100.00%, with a median of 100.00% in 2024.